Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TLX1 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | DLX1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | NOTCH2NL | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
mRNA | KLF16 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | CA1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | AFTPH | GDSC1000 | pan-cancer | AAC | -0.18 | 9e-06 |
mRNA | CD33 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
mRNA | TBPL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | GIMAP6 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | PANX3 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |